Till S. Eichenauer
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16.
Journal: Urologic oncology
Published: February 15, 2022
Y-chromosome loss is frequent in male renal tumors.
Journal: Annals of translational medicine
Published: March 12, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer.
Journal: International urology and nephrology
Published: February 05, 2021
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
Journal: World journal of surgical oncology
Published: March 15, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions.
Journal: Pathology oncology research : POR
Published: February 13, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
Journal: World journal of urology
Published: December 30, 2019
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma.
Journal: World journal of urology
Published: November 06, 2019
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
Journal: Cancer biology & medicine
Published: September 25, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer.
Journal: World journal of urology
Published: September 04, 2019
Last Updated: 09/26/2026